Related Experiment Video
Updated: Jan 8, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Association between Hemoglobin-To-Red Cell Distribution Width Ratio and Left Ventricular Hypertrophy in Non-Dialysis
Li Wang1,2,3,4, Lin Zhang1,2,3,4, Fangfang Xiang1,2,3,4
1Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
Insights
The hemoglobin-to-red cell distribution width ratio (HRR) is linked to lower risk of left ventricular hypertrophy (LVH) in chronic kidney disease (CKD) patients. Lower HRR may indicate increased cardiovascular risk in non-dialysis CKD stages 3-5.
Area of Science:
- Nephrology
- Cardiology
- Biomarkers
Background:
- Left ventricular hypertrophy (LVH) is a significant cardiovascular complication in chronic kidney disease (CKD).
- Anemia and nutritional deficiencies are key drivers of LVH in CKD.
- The hemoglobin-to-red cell distribution width ratio (HRR) may reflect these underlying factors, but its role in LVH development in CKD is not well-established.
Purpose of the Study:
- To investigate the association between the hemoglobin-to-red cell distribution width ratio (HRR) and left ventricular hypertrophy (LVH).
- To evaluate HRR as a potential biomarker for cardiovascular risk in patients with non-dialysis chronic kidney disease (CKD) stages 3-5.
Main Methods:
- A cross-sectional study included 195 patients with non-dialysis CKD stages 3-5.
- Echocardiography diagnosed LVH (LV mass index >115 g/m² men, >95 g/m² women).
- Logistic regression, subgroup, and restricted cubic spline analyses assessed the HRR-LVH association, with mediation analysis exploring the roles of intact parathyroid hormone (iPTH) and N-terminal pro-brain natriuretic peptide (NT-proBNP).
Main Results:
- Patients with LVH exhibited significantly lower HRR compared to those without LVH (0.62 vs. 0.81, P<0.001).
- HRR showed an inverse association with LVH (adjusted OR 0.41 per SD increase, P=0.005).
- The highest HRR tertile was associated with the lowest risk of LVH (adjusted OR 0.23, P=0.044), with iPTH and NT-proBNP mediating a portion of this relationship.
Conclusions:
- The hemoglobin-to-red cell distribution width ratio (HRR) may serve as a simple and effective marker for cardiovascular risk stratification in CKD patients.
- Further prospective research is warranted to determine if interventions targeting HRR can reduce the incidence of LVH.
Introduction:
Left ventricular hypertrophy (LVH) is a common cardiovascular complication in chronic kidney disease (CKD), driven by anemia and nutritional deficiencies. The hemoglobin-to-red cell distribution width ratio (HRR) reflects these factors, but its association with LVH in CKD remains unclear. This study aimed to investigate the relationship between HRR and LVH in non-dialysis CKD stage 3-5 patients.
Methods:
In this cross-sectional study, 195 patients were included. HRR was calculated from hemoglobin and red cell distribution width. LVH was diagnosed by echocardiography (LV mass index >115 g/m2 in men, >95 g/m2 in women). Logistic regression assessed HRR-LVH association, including subgroup and restricted cubic spline analyses. Mediation analysis explored the role of intact parathyroid hormone (iPTH) and N-terminal pro-brain natriuretic peptide (NT-proBNP).
Results:
Patients with LVH (n = 40) had significantly lower HRR (median 0.62 vs. 0.81, p < 0.001). HRR was inversely associated with LVH (adjusted OR 0.41 per SD increase, p = 0.005), with the highest HRR tertile showing the lowest LVH risk (adjusted OR 0.23, p = 0.044). Subgroup analyses showed consistent associations. Mediation analysis indicated iPTH and NT-proBNP explained 37% and 21.1% of the HRR-LVH relationship.
Conclusion:
HRR may be a simple marker for cardiovascular risk stratification in CKD. Prospective studies should assess whether interventions targeting HRR reduce LVH incidence.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy

